Menopause is widely described as the point at which fibroids stop growing — but for some women, this simply does not happen. Understanding why fibroids can persist or even grow after menopause is essential for making informed decisions about treatment.
The Standard Expectation — And Why It Is Not Always True
The conventional wisdom is accurate for most women: fibroids are estrogen-sensitive, and when ovarian estrogen production declines after menopause, fibroids typically shrink or become asymptomatic. However, estrogen does not disappear entirely after menopause — and for some women, enough estrogen-related activity remains to keep fibroids active.
Sources of Estrogen After Menopause
1. Adipose Tissue
Body fat is the primary site of estrogen production after menopause, through aromatase conversion. Women with higher body fat percentages maintain significantly higher circulating estrogen levels — enough, in some cases, to continue stimulating fibroid growth.
2. Hormone Replacement Therapy (HRT)
Women taking estrogen-containing HRT for menopausal symptoms are providing the hormonal fuel that fibroids need to remain active. This does not mean HRT should be avoided categorically — the decision involves weighing benefits and risks — but it is a direct explanation for persistent fibroid activity.
If you are perimenopausal or recently menopausal and struggling with the overlapping challenges of hormonal disruption and weight management alongside fibroid symptoms, Thyrafemme Balance is a programme designed specifically for this hormonal transition phase in women. (Affiliate link.)
3. Environmental Estrogens
Compounds found in plastics, pesticides, cosmetics, and some food packaging mimic estrogen in the body. Reducing exposure — choosing organic produce, using glass instead of plastic, reviewing personal care products — is a practical step with cumulative benefit.
The Bone Density Issue Nobody Warns You About
One underappreciated consequence of the perimenopausal and post-menopausal period — particularly for women who have used GnRH agonists to manage fibroid symptoms — is the impact on bone density. GnRH agonists work by suppressing estrogen, which shrinks fibroids but accelerates bone loss. Even in natural menopause, declining estrogen increases osteoporosis risk significantly.
If bone health is a concern — either from prior GnRH treatment, family history, or perimenopausal status — The Bone Density Solution by Blue Heron Health News is a comprehensive natural programme for protecting and restoring bone density. Worth knowing about at this stage. (Affiliate link.)
What To Do If Your Fibroids Are Still Active After Menopause
If you are post-menopausal and still experiencing fibroid symptoms — pelvic pressure, urinary frequency, bloating, or abnormal bleeding — see a gynaecologist. Post-menopausal bleeding is always worth investigating promptly.
From a lifestyle perspective, maintaining a healthy body weight, reducing environmental estrogen exposure, and following an anti-inflammatory diet all help reduce the estrogenic environment that supports fibroid activity.
